Patent · US Active

Pharmaceutical formulation

US8609645B2 · kind B2 · utility

0Cited by
29References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 10, 2011
Grant dateDec 17, 2013
Priority date—
Expiry dateNov 10, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are novel formulations for the treatment of otic infections in an animal comprising a triazole anti-fungal compound, a quinolone antibiotic and a corticosteroid such as mometasone furoate monohydrate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.